STOCK TITAN

Retractable Tech reported $38.3M in revenue and a $12.6M net loss for fiscal 2025. See the full RVP financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act

Retractable Technologies backs proposed U.S. legislation that would incentivize domestic production of critical medical supplies and related manufacturing investments.

(Neutral)
(Neutral)
Tags
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LITTLE ELM, Texas--(BUSINESS WIRE)-- Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announces its support for Senator Marsha Blackburn’s ONSHORE Manufacturing Act, legislation aimed at strengthening domestic production of critical medical supplies.

The legislation would provide tax incentives for U.S. manufacturing, including investments in advanced manufacturing equipment and facility modernization.

“The ONSHORE Manufacturing Act is the spark American manufacturers need to rebuild our domestic medical base. This legislation ensures that healthcare providers have uninterrupted access to safe, American-made medical products. We are proud to support Senator Blackburn’s efforts in safeguarding our public health infrastructure,” said Sarah Umandap, Government and Public Affairs department of Retractable Technologies, Inc.

Retractable Technologies has manufactured medical devices in Little Elm, Texas for decades while maintaining a global supply chain to support its product portfolio. The Company continues to invest in its domestic manufacturing capabilities while ensuring reliable access to critical medical products.

Retractable Technologies, Inc. looks forward to continuing to work with policymakers on efforts that strengthen American manufacturing and improve the resilience of the nation’s medical supply chain.

Access Senator Blackburn’s press release here: https://www.blackburn.senate.gov/2026/7/blackburn-introduces-legislation-to-increase-domestic-production-of-critical-medical-supplies?utm_source=chatgpt.com

For more information on Retractable, visit its website at www.retractable.com.

Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from such statements.

Factors that could cause or contribute to such differences include, but are not limited to: tariffs; oil prices; material changes in demand; Retractable's ability to maintain liquidity; Retractable's maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.

For further information regarding this release, please contact:
Sarah Umandap
Senior Manager of Government & Public Affairs
Retractable Technologies, Inc.
412-482-7515 or 972-294-1010
sarah.Umandap@retractable.com

Source: Retractable Technologies, Inc.